The SARS-CoV-2 Vaccine Pipeline: An Overview

Current Tropical Medicine Reports - Germany
doi 10.1007/s40475-020-00201-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Can an Effective SARS-CoV-2 Vaccine Be Developed for the Older Population?

Immunity and Ageing
AgingImmunology
2020English

SARS-COV-2 and Infectivity

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Multi-Epitope Vaccine Design Using an Immunoinformatics Approach for 2019 Novel Coronavirus in China (SARS-CoV-2)

2020English

The Wuhan SARS-CoV-2 - What's Next for China

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Early Spread of SARS-Cov-2 in the Icelandic Population

2020English

Monoclonal Antibodies for the S2 Subunit of Spike of SARS-CoV Cross-React With the Newly-Emerged SARS-CoV-2

2020English

While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?

2020English

SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration

Movement Disorders
Neurology
2020English

Potential Host Range of Multiple SARS-like Coronaviruses and an Improved ACE2-Fc Variant That Is Potent Against Both SARS-CoV-2 and SARS-CoV-1

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy